ADVOCATE. CONNECT. INNOVATE.

About

CLSA Board of Directors

Officers


Members

Wade Ackerman

Wade Ackerman

Partner, Covington & Burling LLP

William Annett

Chief Executive Officer OncoCyte

Michael V. Arbige, Ph.D.

Vice President of R&D, DuPont Biosciences

Richard Ascroft

Rick Ascroft

Senior Vice President, Managed Market and Government Affairs, Takeda Pharmaceuticals USA

Ranjeet Banerjee

Worldwide President, Medication Management Solutions, Becton, Dickinson And Company (BD)

David Beier, J.D.

Managing Director, Bay City Capital

Fritz Bittenbender

Senior Vice President, Government Affairs, Genentech

Donald Bobo

Donald E. Bobo, Jr.

Corporate Vice President, Strategy & Corporate Development, Edwards Lifesciences

Ho Sung Cho

Vice President, Biotherapeutics, Celgene

Peter Claude

Peter J. Claude

Partner, PwC

David H. Crean

Managing Director & Partner, Objective Capital Partners

Mark Ginestro

Principal, Healthcare and Life Sciences, KPMG

Paul Hastings

President and Chief Executive Officer, Nkarta Therapeutics

Thomas Hudson

Vice President, Head of Oncology Discovery and Early Development, AbbVie, Inc.

Vera Janushkowsky

Vice President, Government Relations and Public Affairs, Pfizer

Jeff Jonker

President, NGM Biopharmaceuticals

Steve A. Kay, Ph.D., D.Sc.

Director of Convergent Bioscience, Provost Professor of Neurology, Biomedical Engineering and Biological Sciences, University of Southern California

Larry Kwak

Larry Kwak, M.D., Ph.D.

Vice President and Cancer Center Associate Director
Director, Toni Stephenson Lymphoma Center

John Maddalon

Principal, Life Science Practice, Deloitte

Sean McCarthy

President and Chief Executive Officer, CytomX

Shlomo Melmed, MB, ChB, MACP

Executive Vice President for Academic Affairs and Dean of the Medical Faculty at Cedars-Sinai Health System

John Melo

Director, President and Chief Executive Officer, Amyris

Alan Mendelson

Senior Partner and Co-Chair, Venture Technology Group, Latham & Watkins LLP

Keith Murphy

Founder, CEO, and Chairman, Viscient Biosciences

Nicols

John Nicols

President and Chief Executive Officer, Codexis

Chris Nolet

Christian W. Nolet

Partner and Life Sciences Industry Leader, West Region, Ernst & Young

Joshua J. Ofman M.D., M.S.H.S

Senior Vice President, Global Value, Access & Policy, Amgen

Michael G. Raab

Michael G. Raab

President and Chief Executive Officer, Ardelyx

Ganesh Raman, Ph.D.

Associate Vice Chancellor for Research, California State University

Stephen Richardson

Stephen Richardson

Co-Chief Executive Officer, Alexandria Real Estate (ARE)

Beth Roberts

Partner, Hogan Lovells US LLP

Daria Mochly Rosen

Daria Mochly-Rosen, Ph.D.

The George D. Smith Professor in Translational Medicine
Professor, Chemical and Systems Biology, Stanford University School of Medicine

Terry Rosen, Ph.D.

Chief Executive Officer, Arcus Biosciences

George Savage

George Savage M.D.

Co-Founder, Chief Medical Officer, Proteus Digital Health

Tony Semedo

President, Medtronic Japan

Alex Szidon

Head of West Coast Business Development & Licensing, Merck

VanWart

Harold E. Van Wart, Ph.D.

 

Jens Vogel, Ph.D.

Jens Vogel, Ph.D.

President and CEO | Boehringer Ingelheim

Jared Watkin

Senior Vice President, Diabetes Care, Abbott

Rick E Winningham

Chairman and CEO, Theravance Biopharma